首页> 外国专利> Isolated biologically active human lymphotoxin derivative and antibody neutralizing its cytolytic activity, nucleic acid encoding the lymphotoxin derivative, replicable vector comprising the nucleic acid, heterologous cell transformed with the nucleic acid, and method comprising preparing the lymphotoxin derivative.

Isolated biologically active human lymphotoxin derivative and antibody neutralizing its cytolytic activity, nucleic acid encoding the lymphotoxin derivative, replicable vector comprising the nucleic acid, heterologous cell transformed with the nucleic acid, and method comprising preparing the lymphotoxin derivative.

机译:分离的具有生物活性的人淋巴毒素衍生物和中和其溶细胞活性的抗体,编码该淋巴毒素衍生物的核酸,包含该核酸的可复制载体,被该核酸转化的异源细胞以及包括制备该淋巴毒素衍生物的方法。

摘要

Lymphotoxin (I) absolutely free from homologous proteins that are unidentified or present in unknown amounts is new. Unglycosylated (I) is new. Variant (I) in which an amino acid residue in the (I) sequence has been deleted or substd. by another residue, or in which another residue has been inserted, is new. Provided that (I) having a sequence with an amino terminal at Leu(+)1 or His(+)23 is excluded. Nucleic acid encoding (I) and selected from (a)-(c) is new. (a) DNA encoding (I) free from DNA encoding other proteins of the organism from which the DNA originated; (b) DNA encoding (I) free from untranslated intervening sequences; and (c) nucleic acid capable of hybridising to nucleic acid encoding (I), provided that the acid does not have the nucleotide sequence of natural DNA or RNA encoding (I).
机译:绝对不含未知蛋白或未知数量的同源蛋白的淋巴毒素(I)是新的。未糖基化(I)是新的。变体(I),其中(I)序列中的氨基酸残基已被缺失或取代。另一个残基或已插入另一个残基的术语是新的。前提是(I)具有在Leu(+)1或His(+)23具有氨基末端的序列的被排除。选自(a)-(c)的编码(I)的核酸是新的。 (a)编码(I)的DNA,不含编码该DNA来源的生物体其他蛋白质的DNA; (b)编码(I)的DNA不含未翻译的插入序列; (c)能够与编码(I)的核酸杂交的核酸,条件是该酸不具有编码(I)的天然DNA或RNA的核苷酸序列。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号